PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Bone Substitutes”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18Linked to original sources

Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes.

Autogenous cancellous bone graft is used to heal critical-size segmental long bone defects and defects in the maxillofacial skeleton. Harvesting of bone graft is traumatic, causes morbidity of the donor site, and often results in complications. Thus, there is a need for new biologically functional bone graft substitutes that, instead of autogenous bone graft, could be used to facilitate bone regeneration in critical-size defects. Porous biodegradable elastomeric polyurethane scaffolds combined with the patient's own bone marrow could potentially be such bone substitutes. The elastomeric bone substitute prevents shear forces at the interface between bone and rigid, e.g., ceramic bone substitutes and establishes an intimate contact with the native bone ends, thus facilitating the proliferation of osteogenic cells and bone regeneration. Crosslinked 3D biodegradable polyurethane scaffolds (foams) with controlled hydrophilicity for bone graft substitutes were synthesized from biocompatible reactants. The scaffolds had hydrophilic-to-hydrophobic content ratios of 70:30, 50:50, and 30:70. The reactants used were hexamethylene diisocyanate, poly(ethylene oxide) diol (MW = 600) (hydrophilic component), and poly(epsilon-caprolactone) diol (M(w) = 2000), amine-based polyol (M(w) = 515) or sucrose-based polyol (M(w) = 445) (hydrophobic component), water as the chain extender and foaming agent, and stannous octoate, dibutyltin dilaurate, ferric acetylacetonate, and zinc octoate as catalysts. Citric acid was used as a calcium complexing agent, calcium carbonate, glycerol phosphate calcium salt, and hydroxyapatite were used as inorganic fillers, and lecithin or solutions of vitamin D(3) were used as surfactants. The scaffolds had an open-pore structure with pores whose size and geometry depended on the material's chemical composition. The compressive strengths of the scaffolds were in the range of 4-340 kPa and the compressive moduli in the range of 9-1960 kPa, the values of which increased with increasing content of polycaprolactone. Of the two materials with the same amount of polycaprolactone the compressive strengths and moduli were higher for the one containing inorganic fillers. The scaffolds absorbed water and underwent controlled degradation in vitro. The amount of absorbed water and susceptibility to degradation increased with the increasing content of the polyethylene oxide segment in the polymer chain and the presence in the material of calcium complexing moiety. All polyurethane scaffolds induced the deposition of calcium phosphate crystals, the structure and calcium:phosphorus atomic ratio of which depended on the chemical composition of the polyurethane and varied from 1.52-2.0.

Absorbable Implants↗

Bone graft materials and synthetic substitutes.

Bone graft materials quickly are becoming a vital tool in reconstructive orthopedic surgery and demonstrate considerable variability in their imaging appearance. Functions of bone graft materials include promoting osseous ingrowth and bone healing, providing a structural substrate for these processes, and serving as a vehicle for direct antibiotic delivery. The three primary types of bone graft materials are allografts, autografts, and synthetic bone graft substitutes.

Biocompatible Materials↗

Experience with freeze-dried PGLA/HA/rhBMP-2 as a bone graft substitute.

We investigated bone induction by recombinant human bone morphogenetic protein-2 in rodents. The purpose of this study was to evaluate the osteoinductive potential of a resorbable bone substitute fabricated from freeze-dried poly(glycolic acid-co-lactic acid) (PGLA) mixed with hydroxyapatite particles incorporated with bone morphogenetic protein-2 in skull defects of rats (FD-PGLA/HA/rhBMP-2). The FD-PGLA/HA/rhBMP-2 composite or as a control, the FD-PGLA/HA by itself were implanted in skull defects (psi 8 mm) of rats. The samples were harvested at 2 or 4 weeks postoperatively and were studied radiographically and histologically. Four weeks after implantation, the FD-PGLA/HA/rhBMP-2 discs were completely replaced by newly-formed bone possessing bone marrow. In contrast, the defects implanted with FD-PGLA/HA were filled only with fibrous connective tissue. The results suggest that the FD-PGLA/HA/rhBMP-2 composite could be an optimum bone substitute with osteoinductive potential and could function as an alternative bone graft material for autogenous bone in humans.

Absorbable Implants↗

[Hybrid substitute materials for bone. Initial results and perspectives].

Hybrid materials for use as bone substitutes are composed of a synthetic substance to which autologous osteogenic cells are bound. Identification of osteogenic stem cells among bone marrow stromal cells was followed by the demonstration that a host of growth factors, hormones, and cytokines have effects on cultured osteoblasts. Porous ceramics have been developed as vectors for osteogenic cells previously grown in vitro. Porous hydroxyapatite beads bearing stromal cells were used to fill experimental ulnar defects in dogs. The cells were first grown on flat supports then on the three-dimensional hydroxyapatite network. Invasion by histologically identifiable bone tissue was seen in the stroma cell-bearing implants but not in control implants without stromal cells. Materials containing osteogenic cells may prove extremely useful since bone substitutes including hydroxyapatite ceramics are implanted in sites where osteogenic cells are scarce.

Animals↗

Porous ceramics as bone graft substitutes in long bone defects: a biomechanical, histological, and radiographic analysis.

Three porous ceramic bone graft materials were compared with regard to their ability to heal a 2.5 cm defect created surgically in a bilateral canine radius model. The ceramic materials were analyzed at 12 and 24 weeks after surgery and included tricalcium phosphate, hydroxyapatite, and collagen hydroxyapatite, which contained a mixture of 35% tricalcium phosphate and 65% hydroxyapatite with added collagen. Each material was evaluated alone and with added bone marrow aspirate. All the implants were compared with a graft of autogenous cancellous bone in the contralateral radius. Biomechanical testing and radiographic evaluation revealed that the addition of bone marrow aspirate was essential for tricalcium phosphate and hydroxyapatite to achieve results comparable with those of cancellous bone. Collagen hydroxyapatite performed well without the addition of bone marrow, although the addition of marrow did have a positive effect. Further qualitative radiographic and histological analysis demonstrated that tricalcium phosphate was the only ceramic that showed any sign of degradation at 24 weeks. This observed degradation proved to be an important factor in evaluating radiographs because the radiodensity of collagen hydroxyapatite and hydroxyapatite interfered with the determination of radiographic union. At 24 weeks, tricalcium phosphate with bone marrow was the material that performed most like cancellous bone. In this study, the biomechanical and radiographic parameters of tricalcium phosphate with bone marrow were roughly comparable with those of cancellous bone at 12 and 24 weeks. Tricalcium phosphate was the only implant that showed significant evidence of degradation at 24 weeks by both histological and radiographic evaluations, and this degradation took place only after a degree of mechanical competence necessary for weight-bearing was achieved.

Animals↗

Cemented cup stability during lever-out testing after acetabular bone impaction grafting with bone graft substitutes mixes containing morselized cancellous bone and tricalcium phosphate--hydroxyapatite granules.

Bone defects after failed total hip arthroplasty can be reconstructed with impacted morselized bone grafts and a cemented cup. In the near future the amount of bone grafts available for surgical purposes will be insufficient. Ceramic calcium phosphates [tricalcium phosphate (TCP) and hydroxyapatite (HA)] have been widely considered as potential bone graft substitutes or bone graft extenders. In the past, mechanical experiments have been performed to determine implant stability of bone grafts and ceramic TCP-HA granules mixes under a compressive load. However, in-vivo migration studies suggest that shear loading may be equally important. This in-vitro study investigated the initial stability of cups reconstructed with various mixes of bone grafts and ceramic TCP-HA granules in a lever-out situation, where shearing is the predominant loading mode. It was found that the cups reconstructed with mixes of bone graft and TCP-HA granules exhibited greater mechanical stability than the cups reconstructed with bone grafts only. It is concluded that from a mechanical standpoint, when considering shear force resistance, 50-50 per cent volume mix and 25-75 per cent volume mix of morselized cancellous bone graft and TCP-HA granules both provide adequate initial cup stability and can be used for acetabular reconstructions with the bone impaction grafting technique.

Acetabulum↗

[Osteogenesis induced by the combination of growth factor, fibrin glue and coral; towards a substitute of autologous bone graft. An experimental study on the rabbit].

A triple mixture of TGF-beta, fibrin glue and natural coral skeleton granules (madreporic calcium carbonate) was tested in a rabbit bilateral cranioplasty model. Three-dimensional CT scan and histomorphometry demonstrated that, at one month and at two months, this association produced significantly more bone tissue than other associations, especially growth factor or coral alone. The rate of mineralization was significantly increased bilaterally in all animals having received TGF-beta. Coral resorption was also accelerated by growth factor and was replaced by histologically normal bone after two months. We emphasize the potentiation of TGF-beta by fibrin glue and natural coral skeleton and its potential application as a bone substitute.

Animals↗

Recombinant human bone morphogenetic protein-7 and bone marrow as a substitute for bone graft in reconstruction defect of rabbit mandible.

OBJECTIVE: To obtain information on the feasibility of employing recombinant human bone morphogenetic protein-7 (rhBMP-7), mixed with bone marrow as a substitute for autologous bone graft. METHODS: We carried out the study in the University Clinic Center, Sarajevo, Bosnia and Herzegovina, from February 2002 to January 2004. Six New Zealand rabbits underwent hemiresection of the mandible. We placed rhBMP-7 in a concentration of 100 micrograms and collagen (ACS) as carrier mixed with bone marrow in the defects in 3 animals. In another group of 3, we restored the defect by placement of autologous bone graft harvested from the iliac crest. We evaluated the results by the activity of the alkaline phosphatase enzyme (ALP), CT assessment with bone mineral density (BMD) analysis, and clinical and histologic examinations. RESULTS: The ALP activity was significantly higher after 14 days, in the rhBMP7/ACS sites than the bone graft sites (30th day). Mean BMD of tissue induced by rhBMP-7/ACS on the 30th day was 510 mg/cm3 in caudal, and 553 mg/cm3 in sagittal plane, and bone graft tissue was 510 mg/cm3 in caudal and 530 mg/cm3 in sagittal plane. Clinical inspection and histologic examination on the 60th day showed complete bridged defects with abundant woven bone in 2 of 3 rhBMP-7/ACS sites (67%), and no incorporation of the autologous bone graft into the other groups treated sites. CONCLUSION: The rhBMP-7/ACS mixed with bone marrow was very effective in establishing complete bone regeneration into the defects, indicating that it could be an adequate alternative for autologous bone transplantation.

Animals↗

Effects of altered crystalline structure and increased initial compressive strength of calcium sulfate bone graft substitute pellets on new bone formation.

A new, modified calcium sulfate has been developed with a different crystalline structure and a compressive strength similar to many calcium phosphate materials, but with a resorption profile only slightly slower than conventional surgical-grade calcium sulfate. A canine bilateral defect model was used to compare restoration of defects treated with the modified calcium sulfate compared to treatment using conventional calcium sulfate pellets after 6, 13, and 26 weeks. The modified calcium sulfate pellets were as effective as conventional calcium sulfate pellets with regard to the area fraction and compressive strength of newly formed bone in the treated bone defects. Mechanical testing demonstrated that the initial compressive strength of the modified material was increased nearly three-fold compared to that of conventional surgical-grade calcium sulfate. This increase potentially allows for its use in a broader range of clinical applications, such as vertebral and subchondral defects.

Animals↗

[An experimental study of morphologic and element analyses at the interface between bone and substitutive materials for human bone tissues].

The implant materials chosen in this study included hydroxy-poly (calcium natrium phosphate), hydroxyapatite, bioglass ceramic and Ti-6Al-4V. The implants were inserted into the mandibles of dogs. The samples from dogs were regularly observed by X-ray examination, optical microscope, scanning electron microscope and X-ray energy spectrograph. The results showed that all the implants had integrated into the surrounding bone tissue by the third month. During the early stage of the experiment, there were a lot of S, Si at the bone-implant interface. After new bone became mature, the contents of Ca, P increased, but the contents of S, Si decreased at the interface.

Animals↗

Bone grafts and bone induction substitutes.

The use of bone grafts is the basis of all craniofacial surgery. Bone grafts are used to stabilize the open segments, expand the patient's structural boundaries, and fill defects created by trauma or congenital malformations. Bone grafts are harvested from local or distant sites as indicated. Biomaterial implants are used as bone substitutes when it is not possible to use bone grafts.

Adult↗

Modern issues in bone graft substitutes and advances in bone tissue technology.

Autogenous bone grafting is the gold standard in repair of bony defects, fracture nonunion, and promoting arthrodesis. The complications related to obtaining autogenous grafts can be significant, and numerous materials are now available for augmentation or substitution. Allograft materials are highly effective for most applications; however, the surgeon needs to be acutely aware of the source of the tissue, for some tissue banks still use unacceptable processing techniques that destroy the structural and osteoinductive capacities of the graft. DBM products are unregulated and serious concerns exist as to the distribution of inactive products as commercially available to the practicing surgeon. Pressure from the orthopedic community has caused some manufacturers to test their products for activity before distribution. Calcium-based ceramic materials are effective as osteoconductive agents and work well alone as bone void fillers; however, augmentation of these implants with osteoinductive materials should be considered for use in nonunions and arthrodesis. Composite materials that incorporate osteoinductive materials in osteoconductive scaffolds are promising. New technology in isolation and creation of recombinant human bone morphogenic proteins and growth factors, and in the application of autogenous stem cells are emerging as the future of bone grafting procedures.

Animals↗

Substitutes for human cadaveric bone in maxillofacial rigid fixation research.

OBJECTIVE: Various materials have been used as human bone substitutes in rigid fixation research. We hypothesize that these substitutes behave differently than human cadaveric bone in maxillofacial research. STUDY DESIGN: Screw insertion torque and pull-out strength of titanium maxillofacial self-tapping bone screws (1.0 mm and 2.4 mm outer diameter) were measured in cadaveric mandible and in the following materials: bovine rib, porcine rib, photoelastic epoxy, red oak, and 2 types of synthetic mandibles. Results were tested for statistically significant differences (unpaired t test, P <.05) in comparison with human bone. RESULTS: For 1.0-mm screws, statistically significant differences were found for the synthetic mandibles groups and oak groups for insertion torque and porcine rib for pull-out strength. For 2.4-mm screws, statistically significant differences were found for the porcine rib and oak groups for insertion torque and the bovine rib and epoxy groups for pull-out strength. CONCLUSION: The results suggest that human bone can be simulated in fixation studies with bone substitute materials.

Adult↗

The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute.

OBJECTIVES: Autogeneous bone grafting is regarded to be the golden standard for onlay grafts, but it requires a harvesting procedure and the remodeling pattern over time is unpredictable. New materials are constantly being sought to overcome these problems. An in vivo experiment was carried out to evaluate whether (1) porous calcium phosphate cement is a suitable biomaterial for onlay bone grafting, and (2) the addition of transforming growth factor beta 1 (TGF-beta1) accelerates de novo bone formation inside the cement porosity. MATERIAL AND METHODS: A carrier of porous calcium phosphate cement (Calcibon) was designed and 16 rats received one preshaped implant each. In 8 out of 16 implants 0.75 mug TGF-beta1 was applied. The animals were killed after 4 weeks and the characteristics of tissue ingrowth into the onlay graft were evaluated. RESULTS: Histologic and quantitative histomorphometrical measurements demonstrated osteoid-like tissue formation in both experimental groups. The addition of TGF-beta1 did not induce significantly more osteoid-like tissue formation. On the other hand, in TGF-beta-loaded implants, a higher number of pores contained an inflammatory infiltrate. CONCLUSION: This study indicated that porous calcium phosphate cement is a promising material for clinical situations where bone formation has to be supported.

Animals↗

Bone graft substitutes in periodontal and peri-implant bone regeneration.

Regenerative medicine provides different therapy alternatives alongside gold standard autogenous grafts for the treatment of periodontal or peri-implant osseous defects. Continuing progress in the field of alloplastic bone substitutes has yielded promising solutions to the appropriate indications with the membrane technique either alone or in combination with enamel matrix derivatives. Their clinical outcomes, however, still require critical discussion.

Alveolar Bone Loss↗

In vivo osteogenic durability of cultured bone in porous ceramics: a novel method for autogenous bone graft substitution.

BACKGROUND: Bone marrow cells differentiate into bone-forming osteoblasts when cultured in medium supplemented with 15% fetal bovine serum, ascorbic acid, beta-glycerophosphate, and dexamethasone. METHODS: To investigate in vivo osteoblastic activity and bone matrix formation by cultured bone marrow cells, Fischer rat marrow cells were cultured for 2 weeks in porous hydroxyapatite (HA) and then subcutaneously implanted into 7-week-old male syngeneic rats. The implants were harvested after 8 and 52 weeks for biochemical and histological analyses. RESULTS: At both times, formation of lamellar bone accompanied by regeneration of marrow were seen in many of the HA pores. When a fluorochrome (calcein) was administered at 50 weeks after implantation, it was detected in the pores of implants harvested at 52 weeks. Osteoclastic resorption followed by new bone formation was seen in some pores at 52 weeks, indicating that bone remodeling was continuing. The alkaline phosphatase activity of implants harvested at 52 weeks was comparable to that at 8 weeks, whereas the osteocalcin content of the implants harvested at 52 weeks was about twice that at 8 weeks. CONCLUSION: These results demonstrated that there was persistent in vivo osteogenic and hematopoietic activity in the prefabricated bone/HA constructs, and indicated that normal bone tissue was regenerated after grafting of the constructs, which were brittle before implantation. Tissue engineering using HA and cultured marrow cells culture may provide an alternative method of bone transplantation for patients with skeletal disorders, although further in vivo and in vitro experiments are needed.

Alkaline Phosphatase↗